Literature DB >> 1352896

Increased turnover of platelet phosphatidylinositol in schizophrenia.

J K Yao1, P Yasaei, D P van Kammen.   

Abstract

The potential role of receptor-stimulated phosphatidylinositol (PI) hydrolysis in a signal transduction mechanism has been increasingly recognized. Earlier studies have suggested a defect in alpha-adrenergic receptor function in the platelets of schizophrenic patients. Little is known, however, about the mechanisms for PI synthesis, breakdown, and regulation in schizophrenia. The present study was undertaken to investigate the metabolic turnover of inositol phospholipids and inositol phosphates by incorporation of [3H]myoinositol or [32P]orthophosphate into resting and activated platelets of normal controls and schizophrenic patients with and without neuroleptic treatment. After 5 h incubation at 37 degrees C, the majority of [3H]myoinositol was incorporated into platelet PI. Following thrombin-induced platelet activation, there was rapid formation of 3H-labeled inositol phosphates (IPs) with inositol monophosphate (IP1) being the most abundant product. The thrombin-induced formation of platelet IPs was found significantly higher in both haloperidol-stabilized and drug-free schizophrenics than in normal control subjects. When platelets were prelabeled with [32P]orthophosphates, thrombin-induced formation of phosphatidic acid (PA) was also significantly higher in haloperidol-stabilized schizophrenics than in normal controls. It is thought that thrombin-induced platelet activation is mediated through hydrolysis of polyphosphoinositides (poly-PI). The present data thus may reflect an increased signal transduction in schizophrenia, which is mediated through neuroleptic-regulated inositol phospholipid hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352896     DOI: 10.1016/0952-3278(92)90057-p

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  5 in total

Review 1.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

2.  Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

Authors:  John M Pearce; Richard A Komoroski; Robert E Mrak
Journal:  Magn Reson Med       Date:  2009-01       Impact factor: 4.668

3.  Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices.

Authors:  R Li; D M Chuang; R J Wyatt; D G Kirch
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

4.  INFERNO: inferring the molecular mechanisms of noncoding genetic variants.

Authors:  Alexandre Amlie-Wolf; Mitchell Tang; Elisabeth E Mlynarski; Pavel P Kuksa; Otto Valladares; Zivadin Katanic; Debby Tsuang; Christopher D Brown; Gerard D Schellenberg; Li-San Wang
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

Review 5.  Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.

Authors:  Seong-Wook Kim; Taesup Cho; Sukchan Lee
Journal:  Front Psychiatry       Date:  2015-11-17       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.